Kite Pharma Names UCLA Researcher As New Board Member

Santa Monica-based cancer treatment developer Kite Pharma announced on Thursday that it has named Owen N. Witte, M.D., founding director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California Los Angeles (UCLA), to its board of directors. Witte is already on the company's Scientific Advisory Board, where he had been chairman for the past eight years. Witte is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the National Academy of Medicine.